By AuntMinnie.com staff writers

November 8, 2018 -- Radiopharmaceutical developer Navidea Biopharmaceuticals has posted mixed results for its third quarter (end-September 30).

Total revenue for the quarter was $231,000, compared with $224,000 in the third quarter of 2017. The company's net loss for the quarter was $3.8 million, compared with a net loss of $1.4 million in the same quarter of 2017.

Total revenue for the first nine months of 2018 was $1.1 million, compared with $1.4 million for the same period in 2017. Net loss for the first nine months of the year was $13 million, compared with net income of $79 million in 2017.


Copyright © 2018 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: